Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Autolus Therapeutics Plc ADR (NQ: AUTL )

1.860 -0.210 (-10.14%)
Streaming Delayed Price Updated: 4:00 PM EDT, Mar 22, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1,048,872
Open 2.090
Bid (Size) 1.860 (31)
Ask (Size) 1.910 (4)
Prev. Close 2.070
Today's Range 1.850 - 2.090
52wk Range 1.600 - 4.730
Shares Outstanding 52,346,231
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Autolus Therapeutics announces resignation of Chief Financial Officer
From Autolus Therapeutics plc
Via Globe NewsWire
Autolus Therapeutics Has No Business Relationship with Silicon Valley Bank
From Autolus Therapeutics plc
Via Globe NewsWire

Performance

YTD
-0.53%
-0.53%
1 Month
-5.10%
-5.10%
3 Month
-3.63%
-3.63%
6 Month
-11.00%
-11.00%
1 Year
-57.04%
-57.04%

More News

Read More
Tesla To Rally More Than 12%? Here Are 10 Other Analyst Forecasts For Wednesday
Via Benzinga
Autolus Therapeutics Reports Full Year 2022 Financial Results and Operational Progress
From Autolus Therapeutics plc
Via Globe NewsWire
Earnings Outlook For Autolus Therapeutics
Via Benzinga
Why Autolus Therapeutics Stock Is Crashing Today
Via The Motley Fool
Autolus Therapeutics to Report Fourth Quarter and Full Year 2022 Financial Results and Host Conference Call on March 7, 2023
From Autolus Therapeutics plc
Via Globe NewsWire
Autolus Therapeutics announces Board changes
From Autolus Therapeutics plc
Via Globe NewsWire
Autolus Therapeutics Announces Collaboration with Cabaletta Bio for Use of Autolus’ Safety Switch System in Cell Therapies for Autoimmune Disease
From Autolus Therapeutics plc
Via Globe NewsWire
Autolus Announces Partial Exercise of Underwriters' Option to Purchase Additional ADSs
From Autolus Therapeutics plc
Via Globe NewsWire
Autolus Therapeutics to Present Clinical Data Updates at the American Society of Hematology (ASH) Annual Meeting 2022
From Autolus Therapeutics plc
Via Globe NewsWire
Dow Tumbles 100 Points; Silver Rises Over 2%
Via Benzinga
US Stocks Turn Higher; Nasdaq Rises 40 Points
Via Benzinga
Why Ambrx Biopharma Shares Are Trading Higher By Over 550%? Here Are 52 Stocks Moving In Friday's Mid-Day Session
Via Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
Via Benzinga
US Stocks Edge Lower; Producer Prices Increase Higher Than Expected
Via Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
Via Benzinga
Autolus Therapeutics' Leukemia Trial Meets Primary Goal Of Remission Rate, Shares Fall After $150M Capital Raise
Via Benzinga
Why Autolus Therapeutics Shares Are Trading Lower By Around 26%; Here Are 28 Stocks Moving Premarket
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
Via InvestorPlace
Autolus Announces Pricing of Public Offering
From Autolus Therapeutics plc
Via Globe NewsWire
12 Health Care Stocks Moving In Thursday's After-Market Session
Via Benzinga
Autolus Announces Proposed Public Offering in the United States
From Autolus Therapeutics plc
Via Globe NewsWire
Autolus Therapeutics to Receive $70 Million in Milestone Payments from Blackstone Life Sciences
From Autolus Therapeutics plc
Via Globe NewsWire
Autolus Therapeutics announces pivotal Phase 2 FELIX clinical trial has met primary endpoint at interim analysis
From Autolus Therapeutics plc
Via Globe NewsWire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.